GleamWall
中文EN

VNDA Vanda Pharmaceuticals Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1347178 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY8.1%
TTM net income YoY-226.4%
TTM EPS YoY-220.8%
Revenue 3-yr CAGR2.7%
Net income 3-yr CAGR—

Margins

Gross margin93.6%
Operating margin-77.6%
Net margin-119.9%
FCF margin-61.0%
EBITDA margin-77.1%

Returns

ROE-82.5%
ROA-55.9%
ROIC (approx.)-52.6%
Asset turnover0.47x

Leverage & solvency

Liabilities / assets47.7%
Debt / equity0.00x
Current ratio1.54x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.51x
Accruals ratio-27.6%
Payout ratio—
Capex / revenue0.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$216.10M$198.77M
Cost of revenue$13.04M$11.31M
Gross profit$203.06M$187.46M
R&D expense$109.27M$74.43M
SG&A expense$237.95M$146.41M
Operating income-$151.17M-$40.66M
Pretax income-$138.65M-$22.92M
Income tax$81.83M-$4.02M
Net income-$220.47M-$18.90M
EBITDA-$150.06M-$39.80M
EPS (basic)-3.74-0.33
EPS (diluted)-3.74-0.33
Weighted avg. shares (diluted)58.93M58.15M
Balance sheet
Cash & equivalents$84.85M$102.78M
Receivables$54.58M$47.10M
Inventory$1.85M$1.73M
Current assets$347.26M$438.89M
PP&E, net$2.25M$2.13M
Intangibles$117.09M$114.10M
Total assets$488.95M$656.20M
Current liabilities$145.16M$99.98M
Total liabilities$161.76M$117.66M
Shareholders' equity$327.19M$538.55M
Shares outstanding59.10M58.31M
Cash flow statement
Operating cash flow-$109.44M-$15.76M
Capital expenditure$998,000$490,000
Free cash flow-$110.44M-$16.25M
Investing cash flow$94.86M-$17.43M
Financing cash flow-$2.91M-$155,000
Depreciation & amortization$1.10M$859,000
Stock-based compensation$9.47M$12.43M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.